gi-hepatology oncology
Fong Clinical Risk Score for CRC Liver Metastases
Predicts survival after resection of colorectal cancer liver metastases. Five clinical risk factors predict recurrence and survival after hepatectomy.
References
- Fong Y et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg. 1999;230(3):309–321.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- FLIPI — Follicular Lymphoma International Prognostic Index · Cancer Prognosis
- CLL-IPI (International Prognostic Index for CLL) · Cancer Prognosis
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- IMDC Risk Model for Metastatic Renal Cell Carcinoma · Cancer Prognosis
- WPSS — WHO Prognostic Scoring System for MDS · Cancer Prognosis
- MSKCC/Motzer Score for Metastatic RCC · Cancer Prognosis
Drugs
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Denosumab · Anti-RANKL Monoclonal Antibody
- Pamidronate Disodium · IV Bisphosphonate (Paget's Disease / Bone Metastases / Hypercalcaemia)
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.